Murtada Alsaif summarises a recent network meta-analysis, which looks at the efficacy, acceptability and tolerability of antipsychotics for treatment-resistant schizophrenia.
[read the full story...]
Murtada Alsaif summarises a recent network meta-analysis, which looks at the efficacy, acceptability and tolerability of antipsychotics for treatment-resistant schizophrenia.
[read the full story...]
Suzanne Dash considers the findings of a promising new small randomised controlled trial, which aims to reduce delusional conviction in people with schizophrenia who experience persecutory delusions.
[read the full story...]
Samei Huda presents the findings of a new meta-analysis, which explores the prognostic significance of competing ways of defining and measuring brief psychotic episodes.
[read the full story...]
John Baker presents a systematic review of preferences for medication-associated outcomes in mental disorders, which concludes that we just don’t know what value mental health service users place on the different outcomes that come from taking psychiatric medication.
[read the full story...]
Raphael Underwood summarises a recent PSSRU report about the growth in use of early intervention in psychosis services, which highlights opportunities to promote recovery amid concerns on health care sustainability.
[read the full story...]
John Baker is struck by the lack of evidence for crisis intervention for people with severe mental illness, highlighted by a recently updated Cochrane systematic review.
[read the full story...]
John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.
[read the full story...]
Ian Hamilton reviews a recent long-term US study of integrated care for people with a dual diagnosis of substance use and schizophrenia, which concludes that recovery is possible, but it takes time.
[read the full story...]
Joanne Wallace considers the findings of a new Cochrane systematic review on Transcranial Magnetic Stimulation (TMS) for schizophrenia.
[read the full story...]
Tracey Roberts appraises a systematic review of group psychotherapies for schizophrenia, which includes group CBT, music therapy, art therapy and social skills training.
[read the full story...]